Arcturus Therapeutics Holdings, Inc. (ARCT)

47.91
2.20 4.40
NASDAQ
Prev Close 50.13
Open 49.80
Day Low/High 47.00 / 49.80
52 Wk Low/High 24.87 / 129.71
Volume 292.37K
Exchange NASDAQ
Shares Outstanding 26.33B
Market Cap 1.34B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Here's Why I'm Avoiding AstraZeneca Stock

Here's Why I'm Avoiding AstraZeneca Stock

The AZN affair exposes the seedy underbelly of drug manufacturing, and the COVID-19 vaccine is certainly a drug.

Vaccinate Your Portfolio From the Hype

Vaccinate Your Portfolio From the Hype

Let's look at the cold, hard facts around the vaccine rollout.

The Investment Angle of Covid-19

The Investment Angle of Covid-19

Stocks of companies that have Covid-19 vaccine candidates have boomed while those in the treatment space have not.

Stock-Specific Ideas for the Post-Fed Era of Investing

Stock-Specific Ideas for the Post-Fed Era of Investing

Make sure that your portfolio is composed of sane assets for the balance of this crazy year.

Where Health Meets Tech: 7 Testing and Diagnostics Stocks to Know

Where Health Meets Tech: 7 Testing and Diagnostics Stocks to Know

Experts pick their favorite long-term investments in medical diagnostics, testing and laboratory services.

Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine

Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine

When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.

Mr. Market Has Been Dead Right on General Electric

Mr. Market Has Been Dead Right on General Electric

GE's problem can be summarized in one sentence: The company is burning cash.

Luxor Capital Loves REITs

Luxor Capital Loves REITs

The hedge fund is buying up shares of American Realty Capital Trust.